Clinical Trial Record

Return to Clinical Trials

Comparison Of Radiation Exposure To Patients During Endoscopic Retrograde Cholangiopancreatography (ERCP) Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training


2015-11


2021-12


2025-12


1000

Study Overview

Comparison Of Radiation Exposure To Patients During Endoscopic Retrograde Cholangiopancreatography (ERCP) Performed By Endoscopists Trained In Judicious Use Of Fluoroscopy With Those Without Formal Training

Purpose: To compare the radiation exposure in patients during Endoscopic retrograde cholangiopancreatography (ERCP) done by Endoscopists formally trained in judicious use of fluoroscopy versus ERCPs done by Endoscopists without such formal training. Research design: This is an observational study to compare radiation exposure in patients during ERCPs based on formal training. Procedures to be used: None Risks and potential benefits There are no risks associated with this study as it is a retrospective chart review. Potential benefits include the knowledge gained from this study which may be of help to patients in the future. Importance of knowledge that may reasonably be expected to result The knowledge gained from this study may be of help to provide new insights and develop newer guidelines for radiation use in the future.

N/A

  • Pancreatic Cancer
  • OTHER: Endoscopic retrograde cholangiopancreatography - No Intervention have been used other than standard of care
  • HSC-MS-15-0019

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2016-01-04  

N/A  

2021-01-11  

2018-05-02  

N/A  

2021-01-12  

2018-05-15  

N/A  

2021-01  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A


Allocation:
N/A


Interventional Model:
N/A


Masking:
N/A


Arms and Interventions

Participant Group/ArmIntervention/Treatment
: Patients undergoing ERCP by formally trained Endoscopists

Patients who undergo ERCP (Endoscopic Retrograde Cholangio Pancreatography) performed by Endoscopists who are trained on minimum use of fluoroscopy.

OTHER: Endoscopic retrograde cholangiopancreatography - No Intervention have been used other than standard of care

  • No intervention has been used and this is an observational study
: Patients undergoing ERCP by Endoscopists not formally trained

Patients who undergo ERCP (Endoscopic Retrograde Cholangio Pancreatography) performed by Endoscopists who have not received formal training on minimum use of fluoroscopy.

OTHER: Endoscopic retrograde cholangiopancreatography - No Intervention have been used other than standard of care

  • No intervention has been used and this is an observational study
Primary Outcome MeasuresMeasure DescriptionTime Frame
Radiation exposure as assessed by fluoroscopy timeRadiation exposure of patients who undergo ERCP (Endoscopic Retrograde Cholangio Pancreatography) will be assessed by fluoroscopy time, which is indicated by the device used for ERCP. Fluoroscopy time at the time of ERCP will be recorded at the end of the procedure and is documented by the endoscopy technician.at the time of ERCP
Radiation exposure as assessed by total emittanceRadiation exposure of patients who undergo ERCP (Endoscopic Retrograde Cholangio Pancreatography) will be assessed by total emittance, which is indicated by the device used for ERCP. Total emittance at the time of ERCP will be recorded at the end of the procedure and is documented by the endoscopy technician.at the time of ERCP
Secondary Outcome MeasuresMeasure DescriptionTime Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Name: Prithvi Patil, MS

Phone Number: (713) 500-6654

Email: prithvi.b.patil@uth.tmc.edu

Study Contact Backup

Name: Priyanka Priyanka, BAMS, MPH

Phone Number: 7135006457

Email: priyanka.priyanka@uth.tmc.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:
1

    Inclusion Criteria:

  • Any indications for undergoing an ERCP. If a patient undergoes more than one ERCP then it shall be reported as such, as multiple data points.
  • Only those ERCP cases will be included that have been exposed to fluoroscopy (X-ray radiation).
  • Adult populations will be included, all races and belonging to any gender will be included in the study.

  • Exclusion Criteria:

  • Patients who didn't receive ERCP
  • Those in whom the biliary or pancreatic ducts are not cannulated and therefore who do not receive any fluoroscopy
  • Pregnant women
  • Patient population less than 18 years of age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.


    • PRINCIPAL_INVESTIGATOR: Nirav Thosani, MD MHA, The University of Texas Health Science Center, Houston

    Publications

    The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

    General Publications

    No publications available